4//SEC Filing
McCarthy Sean A. 4
Accession 0001610717-25-000234
CIK 0001501989other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:09 PM ET
Size
9.3 KB
Accession
0001610717-25-000234
Insider Transaction Report
Form 4
McCarthy Sean A.
DirectorCEO
Transactions
- Exercise/Conversion
Performance Stock Units
2025-06-13−150,000→ 0 total→ Common Stock (150,000 underlying) - Exercise/Conversion
Common Stock
2025-06-13+150,000→ 1,145,195 total - Sale
Common Stock
2025-06-16$2.69/sh−55,511$149,264→ 1,089,684 total
Holdings
- 93,158(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]This transaction represents the vesting of performance stock units ("PSUs") initially granted on February 2, 2023.
- [F2]Includes 488,750 restricted stock units.
- [F3]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs.
- [F4]Shares held by Sean A. McCarthy 2018 Trust, of which the Reporting Person is trustee.
- [F5]Each PSU represented a contingent right to receive one (1) share of common stock upon vesting.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001654058
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:09 PM ET
- Size
- 9.3 KB